Affiliation:
1. Hepatic and Vascular Diseases Laboratory, Biochemistry and Molecular Biology Department, School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain
Abstract
Atherosclerosis and non-alcoholic fatty liver disease (NAFLD) are pathologies related to ectopic fat accumulation, both of which are continuously increasing in prevalence. These threats are prompting researchers to develop effective therapies for their clinical management. One of the common pathophysiological alterations that underlies both diseases is oxidative stress (OxS), which appears as a result of lipid deposition in affected tissues. However, the molecular mechanisms that lead to OxS generation are different in each disease. Non-coding RNAs (ncRNAs) are RNA transcripts that do not encode proteins and function by regulating gene expression. In recent years, the involvement of ncRNAs in OxS modulation has become more recognized. This review summarizes the most recent advances regarding ncRNA-mediated regulation of OxS in atherosclerosis and NAFLD. In both diseases, ncRNAs can exert pro-oxidant or antioxidant functions by regulating gene targets and even other ncRNAs, positioning them as potential therapeutic targets. Interestingly, both diseases have common altered ncRNAs, suggesting that the same molecule can be targeted simultaneously when both diseases coexist. Finally, since some ncRNAs have already been used as therapeutic agents, their roles as potential drugs for the clinical management of atherosclerosis and NAFLD are analyzed.
Funder
Ministerio de Ciencia e Innovación y Universidades
Complutense University of Madrid
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,Biochemistry,Physiology
Reference129 articles.
1. ROS function in redox signaling;Schieber;Curr. Biol.,2014
2. Oxidative Stress and the Pathogenesis of Alzheimer’s Disease;Zhao;Oxid. Med. Cell. Longev.,2013
3. Włodarski, A., Strycharz, J., Wróblewski, A., Kasznicki, J., Drzewoski, J., and Śliwińska, A. (2020). The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress. Int. J. Mol. Sci., 21.
4. Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases;Vona;Oxid. Med. Cell. Longev.,2019
5. Malekmohammad, K., Sewell, R.D.E., and Rafieian-Kopaei, M. (2019). Antioxidants and Atherosclerosis: Mechanistic Aspects. Biomolecules, 9.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献